Literature DB >> 31857364

Activated protein C anticoagulant activity is enhanced by skeletal muscle myosin.

Mary J Heeb1, José A Fernández2, Atsuki Yamashita2, Olivia R McDowell2, Zihan Guo2, Laurent O Mosnier2, Hiroshi Deguchi2, John H Griffin1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31857364      PMCID： PMC7395292          DOI： 10.3324/haematol.2019.242982

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Mechanisms of thrombus formation.

Authors:  Bruce Furie; Barbara C Furie
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

Review 2.  New fundamentals in hemostasis.

Authors:  Henri H Versteeg; Johan W M Heemskerk; Marcel Levi; Pieter H Reitsma
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

3.  Thrombus formation reimagined.

Authors:  Robert Flaumenhaft
Journal:  Blood       Date:  2014-09-11       Impact factor: 22.113

4.  Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients.

Authors:  Mitchell Jay Cohen; Mariah Call; Mary Nelson; Carolyn S Calfee; Charles T Esmon; Karim Brohi; Jean Francois Pittet
Journal:  Ann Surg       Date:  2012-02       Impact factor: 12.969

5.  A model describing the inactivation of factor Va by APC: bond cleavage, fragment dissociation, and product inhibition.

Authors:  M F Hockin; K M Cawthern; M Kalafatis; K G Mann
Journal:  Biochemistry       Date:  1999-05-25       Impact factor: 3.162

Review 6.  Trauma-induced coagulopathy: The past, present, and future.

Authors:  Lucy Z Kornblith; Hunter B Moore; Mitchell J Cohen
Journal:  J Thromb Haemost       Date:  2019-05-13       Impact factor: 5.824

7.  Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?

Authors:  Karim Brohi; Mitchell J Cohen; Michael T Ganter; Michael A Matthay; Robert C Mackersie; Jean-François Pittet
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

Review 8.  Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane.

Authors:  Edouard M Bevers; Patrick L Williamson
Journal:  Physiol Rev       Date:  2016-04       Impact factor: 37.312

9.  Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.

Authors:  Hiroshi Deguchi; Ranjeet K Sinha; Patrizia Marchese; Zaverio M Ruggeri; Jevgenia Zilberman-Rudenko; Owen J T McCarty; Mitchell J Cohen; John H Griffin
Journal:  Blood       Date:  2016-07-15       Impact factor: 22.113

10.  Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.

Authors:  J Rosing; L Hoekema; G A Nicolaes; M C Thomassen; H C Hemker; K Varadi; H P Schwarz; G Tans
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157
View more
  4 in total

1.  Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.

Authors:  Taichi K Deguchi; Hiroshi Deguchi; Zihan Guo; Darlene J Elias; John H Griffin
Journal:  Thromb Res       Date:  2020-02-27       Impact factor: 3.944

Review 2.  Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.

Authors:  Hiroshi Deguchi; Shravan Morla; John H Griffin
Journal:  J Thromb Haemost       Date:  2020-10-25       Impact factor: 5.824

3.  Procoagulant activities of skeletal muscle and cardiac myosins require both myosin protein and myosin-associated anionic phospholipids.

Authors:  Shravan Morla; Hiroshi Deguchi; José A Fernández; Wolfram Ruf; Rolf A Brekken; John H Griffin
Journal:  Blood       Date:  2021-04-01       Impact factor: 22.113

4.  Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity.

Authors:  Shravan Morla; Hiroshi Deguchi; John H Griffin
Journal:  J Thromb Haemost       Date:  2020-12-10       Impact factor: 5.824
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.